[1] IGLICKI M, GONZÁLEZ D P, LOEWENSTEIN A, et al. Next-generation anti-VEGF agents for diabetic macular oedema[J].Eye (Lond),2022, 36(2):273-277. [2] NASERIPOUR M, HEMMATI S, CHAIBAKHSH S, et al. Cystoid macular oedema without leakage in fluorescein angiography: a literature review[J].Eye (Lond),2023, 37(8):1519-1526. [3] HANSEN M S, RASMUSSEN M, GRAUSLUND J, et al. Proteomic analysis of vitreous humour of eyes with diabetic macular oedema: a systematic review[J].Acta Ophthalmol,2022, 1(5):1043-1051. [4] VARGAS-PEIRANO M, VERDEJO C, VERGARA-MERINO L, et al. Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendations[J].Br J Ophthalmol,2023, 107(3):313-319. [5] DAUTH A, BREBOROWICZ A, RUAN Y, et al. Sulodexide prevents hyperglycemia-induced endothelial dysfunction and oxidative stress in porcine retinal arterioles[J].Antioxidants (Basel),2023, 12(2):388-391. [6] SOUZA M D G C, LEAL I B, CYRINO F Z G A, et al. Effects of different routes of administration and doses of Sulodexide on leukocyte-endothelium interaction and tissue perfusion on an animal model of low flow and high pressure in veins[J].Phlebology,2022, 37(10):721-731. [7] 中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2022年)[J].中华眼底病杂志,2023,39(2):99-124. [8] FUNG S, SYED Y Y. Suprachoroidal space triamcinolone acetonide: a review in uveitic macular edema[J].Drugs,2022, 82(13):1403-1410. [9] MUELLER I, TALKS J S. Should we still be performing macular laser for non-centre involving diabetic macular oedema? No[J].Eye (Lond),2022, 36(3):485-486. [10] GAUDREAULT J, FEI D, BEYER J C, et al. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits[J].Retina,2007, 27(9):1260-1266. [11] 黄丰, 吴春美, 沈宏伟. 舒洛地特对糖尿病患者眼底血流及氧化应激因子水平的影响[J].中国卫生检验杂志, 2019, 29(14):1751-1753. [12] KROGH NIELSEN M, SUBHI Y, RUE MOLBECH C, et al.Imbalances in tissue inhibitors of metalloproteinases differentiate choroidal neovascularization from geographic atrophy[J].Acta Ophthalmol,2019, 97(1):84-90. [13] 李婷, 何学敏, 彭荣东, 等. 舒洛地特通过抑制NOX4/NLRP3通路减轻高糖诱导的视网膜血管损伤[J].中国病理生理杂志, 2020, 36(4):577-587.
2024, Vol. 41 
